Daesung Microbiological Labs. Co., Ltd.

KOSDAQ:A036480 Stock Report

Market Cap: ₩22.7b

Daesung Microbiological Labs Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Daesung Microbiological Labs.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs earnings growth21.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Analysis Article • Aug 06

Daesung Microbiological Labs (KOSDAQ:036480) Is Carrying A Fair Bit Of Debt

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article • May 08

Is Daesung Microbiological Labs (KOSDAQ:036480) Using Too Much Debt?

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Mar 15

Is The Market Rewarding Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) With A Negative Sentiment As A Result Of Its Mixed Fundamentals?

Daesung Microbiological Labs (KOSDAQ:036480) has had a rough month with its share price down 9.5%. We, however decided...
Analysis Article • Feb 17

We're Not Counting On Daesung Microbiological Labs (KOSDAQ:036480) To Sustain Its Statutory Profitability

It might be old fashioned, but we really like to invest in companies that make a profit, each and every year. That...
Analysis Article • Jan 21

Is Daesung Microbiological Labs (KOSDAQ:036480) A Risky Investment?

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
Analysis Article • Dec 31

Update: Daesung Microbiological Labs (KOSDAQ:036480) Stock Gained 83% In The Last Five Years

Generally speaking the aim of active stock picking is to find companies that provide returns that are superior to the...
Analysis Article • Dec 10

Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480) Is Up But Financials Look Inconsistent: Which Way Is The Stock Headed?

Daesung Microbiological Labs' (KOSDAQ:036480) stock is up by 4.3% over the past month. However, the company's...
Analysis Article • Nov 19

Here's Why We Don't Think Daesung Microbiological Labs's (KOSDAQ:036480) Statutory Earnings Reflect Its Underlying Earnings Potential

Statistically speaking, it is less risky to invest in profitable companies than in unprofitable ones. However...

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Daesung Microbiological Labs has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

KOSDAQ:A036480 - Analysts future estimates and past financials data (KRW Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/202625,8706541,4091,784N/A
12/31/202525,9895981,0521,410N/A
9/30/202525,8621,3431,2381,710N/A
6/30/202524,494-7372,3032,784N/A
3/31/202523,412-1,7191,6472,142N/A
12/31/202423,804-1,7691,3072,103N/A
9/30/202424,164-2,7994801,558N/A
6/30/202424,009-2,602-1,116-136N/A
3/31/202425,423-1,147-1,236-141N/A
12/31/202325,562-680-2,494-1,234N/A
9/30/202325,502-674-3,098-1,686N/A
6/30/202324,796441-3,229-720N/A
3/31/202324,871127-2,748-205N/A
12/31/202225,5001,703-1,1601,155N/A
9/30/202225,1672,493-4772,177N/A
6/30/202225,6492,174-5421,694N/A
3/31/202224,7602,568-7461,932N/A
12/31/202123,997866-7662,203N/A
9/30/202123,179-265-7,2411,918N/A
6/30/202123,374335-8,4752,137N/A
3/31/202123,616766-8,9093,580N/A
12/31/202024,8011,519-11,2083,236N/A
9/30/202025,4082,058-10,3961,920N/A
6/30/202024,5151,882-9,4652,926N/A
3/31/202025,8682,510-11,1872,876N/A
12/31/201925,1342,471N/A2,315N/A
9/30/201924,9183,566N/A4,441N/A
6/30/201926,5444,255N/A3,410N/A
3/31/201925,4833,622N/A2,897N/A
12/31/201825,0973,170N/A3,136N/A
9/30/201824,1592,098N/A2,739N/A
6/30/201824,0881,654N/A3,896N/A
3/31/201824,1511,686N/A2,330N/A
12/31/201724,0431,558N/A1,681N/A
9/30/201726,0222,611N/A1,548N/A
6/30/201727,3533,089N/A1,862N/A
3/31/201728,5493,475N/A2,197N/A
12/31/201630,8014,495N/A3,521N/A
9/30/201631,8054,583N/A5,731N/A
6/30/201629,8684,167N/A5,525N/A
3/31/201631,0864,213N/A6,346N/A
12/31/201531,0264,550N/A7,663N/A
9/30/201529,4293,786N/A4,967N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if A036480's forecast earnings growth is above the savings rate (3.1%).

Earnings vs Market: Insufficient data to determine if A036480's earnings are forecast to grow faster than the KR market

High Growth Earnings: Insufficient data to determine if A036480's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if A036480's revenue is forecast to grow faster than the KR market.

High Growth Revenue: Insufficient data to determine if A036480's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if A036480's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/07/08 16:51
End of Day Share Price 2026/07/08 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Daesung Microbiological Labs. Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.